Solventum (SOLV) Cash from Investing Activities (2023 - 2026)
Solventum (SOLV) posted Cash from Investing Activities of -$77.0 million for Q1 2026, up 89.66% on a QoQ basis from -$745.0 million in Q4 2025, and up 32.46% year-over-year from -$58.1 million in Q1 2025.
Solventum (SOLV) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Solventum's Cash from Investing Activities history runs 4 years deep, the most recent figure standing at -$77.0 million for Q1 2026.
- Quarterly Cash from Investing Activities rose 32.46% year-over-year to -$77.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 billion (up 822.96% YoY) and the FY2025 annual result came in at $2.8 billion, up 836.05% from the prior year.
- Cash from Investing Activities was -$77.0 million for Q1 2026 at Solventum, up from -$745.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $3.8 billion in Q3 2025 and bottomed at -$745.0 million in Q4 2025.
- A 4-year average of $162.3 million and a median of -$88.0 million in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities slumped 1450.0% — and 2025, when it jumped 4149.46%.
- Solventum's Cash from Investing Activities stood at -$88.0 million in 2023, then tumbled by 44.32% to -$127.0 million in 2024, then slumped by 486.61% to -$745.0 million in 2025, then surged by 89.66% to -$77.0 million in 2026.
- Business Quant data shows SOLV's Cash from Investing Activities at -$77.0 million in Q1 2026, -$745.0 million in Q4 2025, and $3.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Baxter International | 12.00 Bn | 9.98 Bn | 891.00 Mn | -133.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.00 Mn |
| Mar 31, 2026 | -77.00 Mn |
| Dec 31, 2025 | -745.00 Mn |
| Dec 31, 2025 | -745.00 Mn |
| Sep 30, 2025 | 3.77 Bn |
| Sep 30, 2025 | 3.77 Bn |
| Jun 30, 2025 | -110.00 Mn |
| Jun 30, 2025 | -110.00 Mn |
| Mar 31, 2025 | -114.00 Mn |
| Mar 31, 2025 | -114.00 Mn |
| Dec 31, 2024 | -127.00 Mn |
| Dec 31, 2024 | -127.00 Mn |
| Sep 30, 2024 | -93.00 Mn |
| Sep 30, 2024 | -93.00 Mn |
| Jun 30, 2024 | -58.00 Mn |
| Jun 30, 2024 | -58.00 Mn |
| Mar 31, 2024 | -102.00 Mn |
| Mar 31, 2024 | -102.00 Mn |
| Dec 31, 2023 | -88.00 Mn |
| Dec 31, 2023 | -88.00 Mn |